ID
12003
Beschrijving
Efficacy and Safety of Faster-acting Insulin Aspart Compared to NovoRapid® Both in Combination With Insulin Degludec in Adults With Type 1 Diabetes; ODM derived from: https://clinicaltrials.gov/show/NCT02500706
Link
https://clinicaltrials.gov/show/NCT02500706
Trefwoorden
Versies (1)
- 31-08-15 31-08-15 -
Houder van rechten
ODM derived from: https://clinicaltrials.gov/show/NCT02500706
Geüploaded op
31 augustus 2015
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Eligibility Diabetes NCT02500706
Eligibility Diabetes NCT02500706
- StudyEvent: Eligibility
Beschrijving
Exclusion Criteria
Beschrijving
myocardial infarction; unstable angina; hospitalization; stroke
Datatype
boolean
Alias
- UMLS CUI [1]
- C0027051
- UMLS CUI [2]
- C0002965
- UMLS CUI [3]
- C0007787
- UMLS CUI [4]
- C0038454
Beschrijving
new york heart association classification; class iv; planned
Datatype
boolean
Alias
- UMLS CUI [1]
- C1882087
- UMLS CUI [2]
- C3203629
Beschrijving
ketoacidosis; screening; diabetic; visit; last
Datatype
boolean
Alias
- UMLS CUI [1]
- C0011880
Beschrijving
Inclusion Criteria
Similar models
Eligibility Diabetes NCT02500706
- StudyEvent: Eligibility
C0682069 (UMLS CUI [2])
C0002965 (UMLS CUI [2])
C0007787 (UMLS CUI [3])
C0038454 (UMLS CUI [4])
C3203629 (UMLS CUI [2])